Kester Capital

Kester Capital LLP is a private equity firm based in London, United Kingdom, founded in 2007. The firm specializes in recapitalizations, buyouts, acquisitions, industry consolidation, and growth capital, primarily targeting lower middle market investments and small to medium enterprises (SMEs) seeking institutional capital for the first time. Kester Capital focuses on various sectors, including leisure, business and financial services, consumer electronics, application software, technology, media, telecommunications, hardware and equipment, services, niche markets, and healthcare. The firm typically invests between £5 million and £25 million, with a maximum investment limit of £40 million. Kester Capital aims to engage in controlling, majority, or influential minority investments, primarily within companies that have enterprise values ranging from £10 million to £250 million. The firm invests its own capital and operates primarily in the United Kingdom and Europe.

Sophie Corrodi

Associate

Daisy Driscoll

Associate

David Fernie

Vice President

Patricia Hamel

COO

Robert Henderson

Vice President

Abhishek Majumdar

Partner

Jack Murphy

Associate

Robert Niehaus

Chairman

Peter Ralph

Partner

Cam Steele

Vice President

Ben Woolley

Principal

23 past transactions

Re-Flow

Private Equity Round in 2025
Re-Flow is a Devon-based company specializing in field management software tailored for the construction, highways, traffic management, civil engineering, rail, and landscaping sectors. The software offers a range of features designed to streamline field operations, including the creation of digital job packs that can incorporate relevant PDF documents. Users can schedule events, assign operatives, and update work details in real-time through a user-friendly dashboard, with changes synchronized to a mobile app. The platform also allows for the development of customizable forms that meet regulatory requirements, promoting compliance and facilitating automated workflows. With over 180 firms utilizing its software, including notable industry players, Re-Flow helps organizations enhance efficiency and eliminate operational roadblocks, thereby advancing their field management capabilities.

Emas Pharma

Acquisition in 2024
Emas Pharma Limited is a contract research organization that specializes in providing comprehensive clinical research, medical affairs, pharmacovigilance, and regulatory services to pharmaceutical and biotech companies worldwide. The company offers a range of clinical operations services, including early-phase trials, late-phase clinical trials, and medical writing. Its drug safety services encompass case processing and post-marketing pharmacovigilance, while regulatory functions involve creating regulatory plans and obtaining clinical trial authorizations. Emas Pharma also delivers strategic consultancy, aiding clients with clinical development strategies and portfolio assessments. Its medical affairs services include pre-launch readiness and post-marketing surveillance. With a global presence through offices in the United Kingdom, the United States, Canada, Ireland, and Australia, Emas Pharma is dedicated to supporting the development and commercialization of medicines, ensuring high-quality solutions throughout the product lifecycle. The company, previously known as European Medical Advisory Services Limited, has been operational since 1996 and became a subsidiary of Bionical Limited in 2016.

GXP Engaged Auditing Services

Acquisition in 2023
GXP Engaged Auditing Services is an accounting and auditing firm that provides QM auditing and consultancy services.

MAP Patient Access

Acquisition in 2023
MAP Patient Access is a pharmaceutical manufacturing firm that specializes in market access consulting services for the pharmaceutical and biotech sectors. The company offers a range of services, including early engagement, pricing strategy, health economics, outcomes research, and evidence communication. By providing these services, MAP Patient Access assists its clients in navigating the complex healthcare reimbursement processes globally, ensuring they can effectively position their products in the market.

DC Byte

Acquisition in 2022
DC Byte operates a data and analytics platform designed for the data center sector. It offers a comprehensive view of the market, encompassing both colocation and self-build enterprise assets. The platform integrates user-generated data from data center operators alongside proprietary research, ensuring that the information is continually updated and validated in real-time. This approach enables clients to access a broad range of insights, from global overviews to detailed analytics, supporting informed decision-making within the industry.

Optibrium

Private Equity Round in 2022
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.

Rephine

Acquisition in 2021
Rephine is a global audit and consultancy firm that serves the pharmaceutical, medical device, and biotechnology industries. The company specializes in conducting good manufacturing practice (GMP) and good clinical practice (GCP) audits, as well as providing regulatory consulting services. Rephine also offers GMP training, aimed at equipping clients with the knowledge needed to navigate complex compliance requirements. By addressing common challenges faced by clients in the auditing process, Rephine delivers innovative solutions that help organizations meet the stringent standards set by regulatory bodies. Through its expertise, Rephine supports clients in achieving compliance with all applicable good practices.

Optibrium

Private Equity Round in 2021
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.

You Garden

Acquisition in 2019
You Garden Limited is an online retailer based in Kings Lynn, United Kingdom, specializing in a wide range of gardening products. Founded in 2011, the company offers an extensive selection of flowers, trees, shrubs, fruits, and vegetables, as well as gardening machinery and gifts tailored for gardening enthusiasts. With a focus on providing quality products, You Garden aims to cater to the diverse needs of gardeners, enhancing their gardening experience.

VIXIO Regulatory Intelligence

Private Equity Round in 2019
VIXIO Regulatory Intelligence specializes in providing independent and authoritative insights into the complex landscape of regulatory developments, particularly in the payments and gambling sectors. The company offers a comprehensive platform that delivers in-depth news, legal analysis, and market commentary, catering to a diverse clientele that includes operators, regulators, technology providers, and law firms. By equipping regulatory and legal teams with actionable intelligence, VIXIO enables businesses to navigate regulatory risks effectively and identify new market opportunities. With a commitment to clarity and reliability, VIXIO stands as a trusted resource for organizations seeking to make informed decisions in a rapidly evolving regulatory environment.

ComplianceOnline

Acquisition in 2019
ComplianceOnline is the provider of legal, regulatory and business intelligence for the gambling and payments industries. We specialise in providing high level and independent insights, analysis, data and research through our primary services GamblingCompliance and PaymentsCompliance. Through our advanced web-based technology platform we provide industry professionals with the critical information they need to understand what regulatory change today means for the business opportunities of tomorrow. We pride ourselves on providing the most comprehensive, accurate and up-­to-­date information services and eLearning courses. Based in London, Washington, D.C., California and Taipei, ComplianceOnlines’s team of in-house analysts and journalists boast an unrivaled network of contacts among policymakers, lobbyists and legal experts, as well as a wealth of experience to analyse what regulatory change and market developments today, means for business opportunities tomorrow. Our clients include global law firms and legal professionals, regulators, advisory communities, online and terrestrial operators, lotteries, financial institutions, fintech and start-up companies, and payment technology and service providers. Learn more at: https://gamblingcompliance.com/ https://paymentscompliance.com/

CETA Insurance

Acquisition in 2017
CETA Insurance is a leading provider of personal and commercial insurance distribution services in the United Kingdom. The company specializes in offering a diverse range of insurance products sourced from some of the UK's top insurance providers. CETA employs a tech-enabled online broking platform that facilitates efficient distribution and enhances the customer experience. Additionally, the company supports insurers with tools for quoting, selling, and processing their business, along with an introducer scheme that allows partners to earn income without engaging directly in policy sales. CETA's strong digital marketing capabilities and deep data insights have positioned it as an innovator in the insurance market, fostering recurring customer relationships and establishing a solid presence in its core channels.

Avania

Private Equity Round in 2016
Avania is a full-service contract research organization dedicated to managing clinical studies for a range of products, including medical devices, in vitro diagnostics, biologics, and combination products. The company specializes in providing tailored contract research services specifically for the medical device sector, guiding clients through all phases of product development, from feasibility studies to post-approval trials. Avania's expertise encompasses advanced technologies and novel products, enabling it to offer customized and scalable solutions that enhance operational efficiencies and facilitate the progression of medical technology on an international scale.

Frontier Medical Group

Private Equity Round in 2013
Frontier Medical Group is a prominent supplier of consumable products and services to healthcare providers in the UK, Europe, and internationally. The company specializes in the manufacturing of pressure area care and infection control products, which play a critical role in maintaining patient safety and hygiene. Its product offerings include sharps disposal containers, clinical waste disposal containers, and harm reduction products, all designed to address the specific needs of healthcare environments. Through its commitment to quality and innovation, Frontier Medical Group supports healthcare professionals in delivering effective and safe patient care.

Garrets International

Acquisition in 2012
Garrets International specializes in outsourced marine catering management for the commercial shipping industry, overseeing around 1,000 vessels for prominent shipping companies. The firm focuses on helping vessel owners minimize administrative costs through a range of services. These services include ensuring hygiene and food safety, managing food procurement, training cooks, and enhancing crew welfare and retention. By addressing nutrition and food waste reduction, Garrets International streamlines catering processes for the maritime sector, ensuring efficient and effective management of onboard provisions.

AgriBriefing

Acquisition in 2012
AgriBriefing is a business media company based in London, UK, that specializes in providing pricing benchmarks, data analytics, and market intelligence for the global agriculture and food sectors. Founded in 2010 by media executives Neil Thackray and Rory Brown, the company initially launched TheMediaBriefing to serve the media industry before expanding its focus to agriculture in 2012 through the acquisition of Farmers Guardian and Pulse. AgriBriefing has further enhanced its portfolio with acquisitions such as LAMMA, a leading agricultural equipment exhibition, and Agrimoney, a recognized intelligence portal for international agribusiness. The company offers critical market data and proprietary insights to approximately 250,000 farming decision-makers, enabling them to make informed commercial and strategic decisions.

Industry Dynamics

Private Equity Round in 2011
Industry Dynamics is a business-to-business events organizer that specializes in medium and large-scale events across Europe and North America. The company provides a diverse array of services, including training and online lead generation, catering to key sectors such as energy, pharmaceuticals, food and beverage, supply chain, and business services. By focusing on these verticals, Industry Dynamics aims to facilitate networking and knowledge sharing among professionals in various industries.

Chiltern International

Private Equity Round in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.

Chiltern International

Acquisition in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.

Travel Entertainment Group

Private Equity Round in 2008
Travel Entertainment Group, Ltd. provides entertainment services to the airline industry.

Ironshore Insurance

Private Equity Round in 2007
Ironshore provides broker-sourced specialty property and casualty insurance coverages for varying risks located throughout the world. Select specialty coverages are underwritten at Lloyd’s through Ironshore’s Pembroke Syndicate 4000. The Ironshore group of companies is rated A (Excellent) by A.M Best with a Financial Size Category of Class XIV. Pembroke Syndicate 4000 operates within Lloyd’s where the market rating is A (Excellent) by A.M. Best, AA- (Very Strong) by Fitch, and A+ (Strong) by Standard & Poor’s.

Xanthus Pharmaceuticals

Series B in 2006
Xanthus Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the discovery, development, acquisition, and commercialization of small-molecule therapeutics targeting cancer and autoimmune disorders. The company specializes in creating innovative treatments that address unmet medical needs in these critical areas. Through its focused approach, Xanthus Pharmaceuticals aims to advance healthcare solutions that improve patient outcomes and enhance the quality of life for those affected by these diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.